SCHEMBL24744819

SCHEMBL24744819

CCC1(CC)CN(CCO)C1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11013490 0.79 ALDH1A1 (0.36) ALDH1A1KMT2A
SCHEMBL25922429 0.79 DRD2 (0.30)
SCHEMBL18800954 0.76 LMNA (0.41) ALDH1A1KMT2A
SCHEMBL24744823 0.75
SCHEMBL22297219 0.74 ALDH1A1 (0.33) ALDH1A1
SCHEMBL27798489 0.73 GLB1 (0.39)
SCHEMBL23482056 0.73 TSHR (0.30)
SCHEMBL24171294 0.71 PRMT3 (0.33)
SCHEMBL25706816 0.71
SCHEMBL24670563 0.70 KDM4E (0.37) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed